CD38 and COVID-19: Furthermore, the expression level of HLA-DR and CD38 on CD4+ and CD8+ T cells in peripheral blood significantly increased in patients with COVID-19, and the maximum values were found in patients with a poor disease outcome [88] (Figure 4).